No needles, just a spray in mouth: Painless insulin likely to enter markets soon | 5 things we know so far
even to a normal working person, Telangana Today reported. The Telangana Today report cited results of a study that was recently conducted among dogs. The study, carried out by Palamur Biosciences, "provide ample proof of effectiveness of our oral insulin", the report said while the company's statement.
Meanwhile, the Times of India reported that during the study conducted on dogs, Ozulin demonstrated a bioavailability of over 91 percent compared to injectable insulin. Bioavailability is the degree and rate at which a substance (such as a drug) is absorbed into a living system or is made available at the site of physiological activity K Koteswara Rao, the co-founder and director of NiedlFree technologies, explained that NiedlFree Technologies achieved this breakthrough by encapsulating human insulin into functionalised nano particles, ensuring optimal delivery into the bloodstream with a prolonged release, the report said. ALSO READ: Air pollution linked to higher incidence of type 2 diabetes: Report The company said the doses were administered in the form of a liquid spray into the mouth.
According to a Times of India report, the spray can be used by both animal and humans. The Times of India said that the company plans to introduce the oral insulin spray for pets, primarily dogs and cats, by 2024-25. Meanwhile, Telangana Today cited the company as saying that Ozulin is set to hit the market in two-three years time around 2025-26.
Read more on livemint.com
